Presynaptic excitability as a potential target for the treatment of the traumatic cerebellum

Pharmacology

Volumn 71, Issue 4, 2004, Pages 192-198

  Ai, Jinglu ^a   Baker, Andrew ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cerebellum; Experimental treatment; Neurotransmission; Presynaptic excitability; Purkinje cell death; Traumatic brain injury; Traumatic cerebellum

Indexed keywords

GLUTAMIC ACID; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR ANTAGONIST; NEUROTRANSMITTER UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; ELECTROPHYSIOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NERVE EXCITABILITY; NEUROPHYSIOLOGY; NONHUMAN; PRESYNAPTIC NERVE; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN INJURIES; CEREBELLUM; ELECTRIC STIMULATION; GLUTAMATES; GLUTAMIC ACID; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, PRESYNAPTIC; SYNAPTIC TRANSMISSION;

EID: 4043153466     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000078085     Document Type: Article

References (25)

1. Sosin DM, Sniezek JE, Thurman DJ: Incidence of mild and moderate brain injury in the United States, 1991. Brain Inj 1996;10:47-54.
2. Laurer HL, McIntosh TK: Pharmacologic therapy in traumatic brain injury: Update on experimental treatment strategies. Curr Pharm Des 2001;7:1505-1516.
3. Maas AI: Neuroprotective agents in traumatic brain injury. Expert Opin Investig Drugs 2001;10:753-767.
4. Fukuda K, Aihara N, Sagar SM, Sharp FR, Pitts LH, Honkaniemi J, Noble LJ: Purkinje cell vulnerability to mild traumatic brain injury. J Neurotrauma 1996;13:255-266.
5. Faden AI, Demediuk P, Panter SS, Vink R: The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989;244:798-800.
6. Allen JW, Ivanova SA, Fan L, Espey MG, Basile AS, Faden AI: Group II metabotropic glutamate receptor activation attenuates traumatic neuronal injury and improves neurological recovery after traumatic brain injury. J Pharmacol Exp Ther 1999;290:112-120.
7. Gong QZ, Delahunty TM, Hamm RJ, Lyeth BG: Metabotropic glutamate antagonist, MCPG, treatment of traumatic brain injury in rats. Brain Res 1995;700:299-302.
8. Ai J, Baker A: Presynaptic hyperexcitability at cerebellar synapses in traumatic injury rat. Neurosci Lett 2002;332:155-158.
9. Baker AJ, Phan N, Moulton RJ, Fehlings MG, Yucel Y, Zhao M, Liu E, Tian GF: Attenuation of the electrophysiological function of the corpus callosum after fluid percussion injury in the rat. J Neurotrauma 2002;19:587-599.
10. Kondo M, Sumino R, Okado H: Combinations of AMPA receptor subunit expression in individual cortical neurons correlate with expression of specific calcium-binding proteins. J Neurosci 1997;17:1570-1581.
11. Chesnut RM, Marshall LF, Klauber MR, Blunt BA, Baldwin N, Eisenberg HM, Jane JA, Marmarou A, Foulkes MA: The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993;34:216-222.
12. Malenka RC, Kocsis JD, Ransom BR, Waxman SG: Modulation of parallel fiber excitability by postsynaptically mediated changes in extracellular potassium. Science 1981;214:339-341.
13. Yuan Y, Atchison WD: Comparative effects of methylmercury on parallel-fiber and climbingfiber responses of rat cerebellar slices. J Pharmacol Exp Ther 1999;288:1015-1025.
14. Samuelsson C, Kumlien E, Flink R, Lindholm D, Ronne-Engstrom E: Decreased cortical levels of astrocytic glutamate transport protein GLT-1 in a rat model of posttraumatic epilepsy. Neurosci Lett 2000;289:185-188.
15. Ito M: Cerebellar long-term depression: Characterization, signal transduction, and functional roles. Physiol Rev 2001;81:1143-1195.
16. Blitzblau R, Gupta S, Djali S, Robinson MB, Rosenberg PA: The glutamate transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures. Eur J Neurosci 1996;8:1840-1852.
17. Vornov JJ, Tasker RC, Park J: Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/kainate receptors in organotypic hippocampal cultures. Exp Neurol 1995;133:7-17.
18. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF: Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16:675-686.
19. Fitzjohn SM, Irving AJ, Palmer MJ, Harvey J, Lodge D, Collingridge GL: Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices. Neurosci Lett 1996;203:211-213.
20. Nakanishi S: Metabotropic glutamate receptors: Synaptic transmission modulation and plasticity. Neuron 1994;13:1031-1037.
21. Conn PJ, Pin JP: Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 1997;37:205-237.
22. Ferraguti F, Pietra C, Valerio E, Corti C, Chiamulera C, Conquet F: Evidence against a permissive role of the metabotropic glutamate receptor 1 in acute excitotoxicity. Neuroscience 1997;79:1-5.
23. Lujan R, Roberts JD, Shigemoto R, Ohishi H, Somogyi P: Differential plasma membrane distribution of metabotropic glutamate receptors mGluR1 alpha, mGluR2 and mGluR5, relative to neurotransmitter release sites. J Chem Neuroanat 1997;13:219-241.
24. Ohishi H, Shigemoto R, Nakanishi S, Mizuno N: Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat. Neuroscience 1993;53:1009-1018.
25. Anwyl R: Metabotropic glutamate receptors: Electrophysiological properties and role in plasticity. Brain Res Brain Res Rev 1999;29:83-120.